Biotech Values

[Mbledug Dewe]

I found the answer to my question and the reason behind the response of MNTA IR saying "both are correct":

------------------------------------

From MNTA IR:

The Goldman report states that we received the request in the form of a “non-approvable letter” and responded in the form of a “minor amendment”, both of which are correct.

------------------------------------

FDA has eliminated the terms "approvable letter" and "non-approvable letter" sometime in 2008:

http://www.bizjournals.com/eastbay/stories/2008/07/07/daily41.html

As MNTA received the letter before this time, it was still called a "non-approvable letter" and as MNTA responded after the elimination of the terms, it responded in the form of a "minor amendment" to suit the new term of the letter, i.e., a "minor deficiency letter".